Related references
Note: Only part of the references are listed.Reversal of Profound, High-dose Rocuronium–induced Neuromuscular Blockade by Sugammadex at Two Different Time Points
Friedrich K. Pühringer et al.
ANESTHESIOLOGY (2009)
Pharmacokinetic-Pharmacodynamic Model for the Reversal of Neuromuscular Blockade by Sugammadex
Batt A. Ploeger et al.
ANESTHESIOLOGY (2009)
Multicentre, parallel-group, comparative trial evaluating the efficacy and safety of sugammadex in patients with end-stage renal failure or normal renal function
L. M. Staals et al.
BRITISH JOURNAL OF ANAESTHESIA (2008)
Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex - A multicenter, dosefinding and safety study
Hans D. de Boer et al.
ANESTHESIOLOGY (2007)
Selective relaxant binding agents for reversal of neuromuscular blockade
Anton Bom et al.
CURRENT OPINION IN PHARMACOLOGY (2007)
Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study - Efficacy, safety, and pharmacokinetics
Harald J. Sparr et al.
ANESTHESIOLOGY (2007)
Reversal of rocuronium-induced neuromuscular block with the novel drug sugammadex is equally effective under maintenance anesthesia with propofol or sevoflurane
Bernard F. Vanacker et al.
ANESTHESIA AND ANALGESIA (2007)
Randomized, dose-finding, Phase II study of the selective relaxant binding drug, sugammadex, capable of safely reversing profound rocuronium-induced neuromuscular block
Scott B. Groudine et al.
ANESTHESIA AND ANALGESIA (2007)
Effective reversal of moderate rocuronium- or vecuronium-induced neuromuscular block with sugammadex, a selective relaxant binding agent
Koen Suy et al.
ANESTHESIOLOGY (2007)
Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex - A dose-finding and safety study
IF Sorgenfrei et al.
ANESTHESIOLOGY (2006)
Org 25969 (sugammadex), a selective relaxant binding agent for antagonism of prolonged rocuronium-induced neuromuscular block
M Shields et al.
BRITISH JOURNAL OF ANAESTHESIA (2006)
First human exposure of org 25969, a novel agent to reverse the action of rocuronium bromide
F Gijsenbergh et al.
ANESTHESIOLOGY (2005)
Reversal of neuromuscular blockade and simultaneous increase in plasma rocuronium concentration after the intravenous infusion of the novel reversal agent Org 25969
O Epemolu et al.
ANESTHESIOLOGY (2003)
Share Paper
